Ethical Investment in Global Public Health Security: A Health Policy and Bioethics Consortium
Health emergencies around the world in recent years have included SARS, MERS, Ebola, and influenza. These epidemics have caused substantial mortality, destabilized governments, and served as significant risks to economic stability and development. So what steps can we take to enhance global health security? What are the ethical considerations in responding to global pandemics?
This event is free and open to the public, but space is limited and registration is required. Please note that attendees will need to show ID in order to enter the venue. Register now!
Vanessa B. Kerry, MD, MSc, Associate Professor of Medicine, Harvard Medical School and CEO, Seed Global Health
Lawrence O. Gostin, JD, Linda D. & Timothy J. O'Neill Professor of Global Health Georgetown Law School
The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations.
They are organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.